Cannabinoid 2 (CB2) receptor involvement in the down-regulation but not up-regulation of serum ige levels in immunized mice

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 3, 2012, Pages 591-598

  Newton, Catherine A ^a   Klein, Thomas W ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Allergy; Cannabinoid receptors; CB2; Delta 9 tetrahydrocannabinol; GPR55; Immunoglobulin E (IgE)

Indexed keywords

1 ALPHA LYSOPHOSPHATIDYLINIOSITOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; DRONABINOL; GP1A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; DOWN-REGULATION; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB2; SERUM; UP-REGULATION;

EID: 84866107016     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9361-4     Document Type: Article

References (26)

1. Agudelo M, Newton C, Widen R, Sherwood T, Nong L, Friedman H, Klein T (2008) Cannabinoid receptor 2 (CB2) mediates immunoglobulin class switching from IgM to IgE in cultures of murinepurified B lymphocytes. J Neuroimmune Pharmacol 3:35-42
2. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Mo FM, Liu J, Kunos G (2005) Evidence for novel cannabinoid receptors. Pharmacol Ther 106:133-145 (Pubitemid 40613055)
3. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396:141-149 (Pubitemid 30265571)
4. Jan TR, Farraj AK, Harkema JR, Kaminski NE (2003) Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicol Appl Pharmacol 188:24-35 (Pubitemid 36369386)
5. Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5:400-411 (Pubitemid 40685989)
6. Klein TW, Cabral GA (2006) Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharmacol 1:50-64 (Pubitemid 44257500)
7. Klein TW, Newton CA, Nakachi N, Friedman H (2000) Delta 9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol 164:6461-6466 (Pubitemid 30408829)
8. Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A.
9. Lu T, Newton C, Perkins I, Friedman H, Klein TW (2006a) Role of cannabinoid receptors in Delta-9-Tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. Eur J Pharmacol 532:170-177
10. Lu T, Newton C, Perkins I, Friedman H, Klein TW (2006b) Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J Pharmacol Exp Ther 319:269-276 (Pubitemid 44455132)
11. Mackie K (2006) Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46:101-122 (Pubitemid 43271185)
12. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13:492-497 (Pubitemid 46559830)
13. Newton CA, Klein TW, Friedman H (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-Tetrahydrocannabinol injection. Infect Immun 62:4015-4020 (Pubitemid 24264350)
14. Newton CA, Chou PJ, Perkins I, Klein TW (2009) CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-Tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection. J Neuroimmune Pharmacol 4:92-102
15. Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A possible natural ligand for GPR55. J Biochem 145:13-20
16. Rachelefsky GS, Opelz G, Mickey MR, Lessin P, Kiuchi M, Silverstein MJ, Stiehm ER (1976) Intact humoral and cell-mediated immunity in chronic marijuana smoking. J Allergy Clin Immunol 58:483-490
17. Roper RL, Conrad DH, Brown DM, Warner GL, Phipps RP (1990) Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. J Immunol 145:2644-2651 (Pubitemid 20374591)
18. Ross RA (2009) The enigmatic pharmacology of GPR55. Trends Pharmacol Sci 30:156-163
19. Roth MD, Baldwin GC, Tashkin DP (2002) Effects of delta-9- Tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids 121:229-239 (Pubitemid 36044554)
20. Roy S, Balasubramanian S, Sumandeep S, Charboneau R, Wang J, Melnyk D, Beilman GJ, Vatassery R, Barke RA (2001) Morphine directs T cells toward T(H2) differentiation. Surgery 130:304-309 (Pubitemid 32721684)
21. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092-1101 (Pubitemid 350166046)
22. Sharir H, AboodME (2010) Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 126:301-313
23. Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE (2008) Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-Tetrahydrocannabinol. J Leukoc Biol 84:1574-1584 (Pubitemid 352774493)
24. Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139:225-236
25. Walter L, Stella N (2004) Cannabinoids and neuroinflammation. Br J Pharmacol 141:775-785 (Pubitemid 38446178)
26. Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, Dubinett SM (2000) Delta-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol 165:373-380 (Pubitemid 30429529)